Search for on  
Sunday, November 08, 2009
     
 Home
 About CWA
 Join CWA
 Give/Donate
- Donate Now
- More Ways to Give
 Get Involved
- Federal
- State/Local
 Media Center
- CWA Experts
- Press Releases
- CWA In The News
- CWA Op/Eds
 Legislation
 Beverly LaHaye
 Institute
 Culture and Family Issues
 Legal Studies
 Family Voice
- Subscribe Online!
 Multimedia
 Shop CWA
 About CWA
 CWALAC
 Project 535
 Employment
 Internships
 Brochures
 Fact Cards
 Recently on CWA
 Links

CWA of Iowa – Veterans Event
November 9, 2009
Des Moines, IA

CWA of Hawaii – Now is the Time – Now More Than Ever
November 9, 2009
Hilo, HI

CWA of Central California – Beyond the TEA Parties
November 14, 2009
San Jose, CA

CWA of Iowa – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide


 

CWA: GAO Report on Plan B Finds What Parents Would Want – FDA Handled Controversial Drug With Great Caution     11/14/2005

Washington, D.C.—Concerned Women for America (CWA) commended the Food & Drug Administration for treating with great concern the application to make the morning-after pill Plan B available over-the-counter (OTC), as found in a report released today by the Government Accountability Office (GAO).

“Making Plan B over-the-counter would needlessly expose adolescents to risks and reduce access to health care to those in need of it,” said Wendy Wright, CWA’s Executive Vice President. “The debate is whether it should be available without a prescription. Barr Labs never bothered to adequately research whether it could be taken safely by the full population who would purchase it from drugstore shelves. And proponents make false claims – which their own studies refute – that it would halve the number of pregnancies and abortions.

“Thankfully, the FDA’s leadership did what others refused to do – consider whether a drug’s easy availability would present unique health risks to women and girls.

“The FDA was asked to make a high dose of a drug available OTC when the low dose requires a prescription. Doctors screen women for medical conditions before prescribing the morning-after pill and check for conditions that a woman may not realize she’s acquired which can lead to infertility and death.

“The FDA should consider that its decision to make a drug as easy to get as toothpaste could lead to a proliferation of deadly sexually transmitted diseases.”

Wendy Wright testified at the FDA Advisory Committee hearing on OTC for Plan B. CWA filed an extensive report earlier this month with the FDA, which argued that it lacks the authority to approve Plan B with an age restriction and that OTC status for Plan B would put women at medical risk.



Bookmark and Share

For Information Contact:
Demi Bardsley
(202) 309-5978
media.cwfa.org

Printer Friendly Version

Recent Articles
Knock, Knock: We’re Here!
CWA joins Michele Bachmann's 'House Call' on Congress
Pelosi’s Bill Supported by Partial-Birth Abortionist
Now's the Time to Stop the Abomination of ObamaCare
ObamaCare = Coerced Abortions
Petitions Against Federal Funding of Abortion Delivered to Capitol Hill
ObamaCare and the Doctor Shortage
40 Days for Life
Testimony Before the Senate Health, Education, Labor, and Pensions Committee
"Defender La Vida Juntos: Defending Life Together"
American Pro-Lifers to Greet Spain’s Prime Minister

 

 
 

 

Concerned Women for America
1015 Fifteenth St. N.W., Suite 1100
Washington, D.C. 20005
Phone: (202) 488-7000
Fax: (202) 488-0806

Feedback / Questions? || Problem with this page? || Archives



 
    ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... .....